These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37121538)

  • 1. ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.
    An X; Wu W; Yang L; Dong J; Liu B; Guo J; Chen J; Guo B; Cao W; Jiang Q
    Transl Res; 2023 Sep; 259():62-71. PubMed ID: 37121538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 Promotes Osteosarcoma Metastasis via an m6A-dependent Epigenetic Activity of CBX4.
    Huo XS; Lu D; Chen DG; Ye M; Wang XW; Shang FS
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):120. PubMed ID: 38538251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability
    Zhou X; Yang Y; Li Y; Liang G; Kang D; Zhou B; Li Q
    Front Cell Dev Biol; 2021; 9():784719. PubMed ID: 35096816
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
    Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
    Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation.
    Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ
    J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1.
    Song D; Wang Q; Yan Z; Su M; Zhang H; Shi L; Fan Y; Zhang Q; Yang H; Zhang D; Liu Q
    Biol Direct; 2024 Jun; 19(1):44. PubMed ID: 38849910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
    Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
    Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Wang H; Xu B; Shi J
    Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
    Ling Z; Chen L; Zhao J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function.
    Du Y; Hou G; Zhang H; Dou J; He J; Guo Y; Li L; Chen R; Wang Y; Deng R; Huang J; Jiang B; Xu M; Cheng J; Chen GQ; Zhao X; Yu J
    Nucleic Acids Res; 2018 Jun; 46(10):5195-5208. PubMed ID: 29506078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.
    Zhu D; Liu Y; Chen J; Wang Q; Li Y; Zhu Y; Feng J; Jiang J
    J Transl Med; 2022 Jul; 20(1):298. PubMed ID: 35794583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A-dependent upregulation of TRAF6 by METTL3 is associated with metastatic osteosarcoma.
    Wang J; Wang W; Huang X; Cao J; Hou S; Ni X; Peng C; Liu T
    J Bone Oncol; 2022 Feb; 32():100411. PubMed ID: 35145841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.